Product Information
IVABRADINE HCL 7.5 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.6606 per EA under NDC 31722005460. Its NADAC has been published 96 times since Oct 23, 2024.
FDA first approved this application on Oct 5, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722005460
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IVABRADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213366FDA Approved
10/5/2022
TE Code
AB
On Market Since
10/5/2022
Pharmacological Classes
Price Statistics
The NADAC for IVABRADINE HCL 7.5 MG TABLET has been published 96 times since Oct 23, 2024, and over the history we have for it it has declined 89.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6606 per EA |
|---|---|
| All-time high | $6.2147 (Nov 13, 2024) |
| All-time low | $0.6606 (Aug 19, 2026) |
| 52-week high | $2.9105 |
| 52-week low | $0.6606 |
| Median price | $2.6031 |
| Average price | $2.7932 |
| Largest weekly change | -25.7% (Feb 18, 2026) |
| Weeks tracked | 96 |
| Tracking since | Oct 23, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IVABRADINE HCL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IVABRADINE HCL 7.5 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.6606 per EA (NDC 31722005460), effective Aug 19, 2026.
How has the price of IVABRADINE HCL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for IVABRADINE HCL 7.5 MG TABLET has declined 89.4%. It has been tracked across 96 weekly CMS publications since Oct 23, 2024.
What are the highest and lowest recorded NADAC prices for IVABRADINE HCL 7.5 MG TABLET?
Since Oct 23, 2024, the NADAC for IVABRADINE HCL 7.5 MG TABLET has ranged from a low of $0.6606 (Aug 19, 2026) to a high of $6.2147 (Nov 13, 2024), with a median of $2.6031 per EA.
Are there cheaper alternatives to IVABRADINE HCL 7.5 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IVABRADINE HCL 7.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures IVABRADINE HCL 7.5 MG TABLET?
IVABRADINE HCL 7.5 MG TABLET (NDC 31722005460) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.